This therapeutic intervention is particularly important for the treatment of ischemic and inflammatory disorders, age-related macular degeneration, psoriasis, and cancer, where false regulation of VEGF signaling contributes to the progression of the disease [3,4,5]. The gene discussed is VEGFA; the disease is age-related macular degeneration.